InDevR launches VaxArray Measles and Rubella Kit for improved vaccine antigen characterization
BOULDER -- InDevR, Inc. announced commercial availability of its VaxArray Measles and Rubella (MR) antigen quantification kit. Funded by the Bill and Melinda Gates Foundation with the goal of... Read More
Tuesday January 19, 2021 0 comments
InDevR expands commercial portfolio for coronavirus vaccine characterization
BOULDER -- InDevR, Inc. , a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial... Read More
Thursday December 10, 2020 0 comments
InDevR delivers commercial multiplex Coronavirus SeroAssay kit and testing services for vaccine development
BOULDER -- InDevR, Inc. , a leader in novel analytical technologies that support the development and production of vaccines and biotherapeutics, announced commercial availability of its COVID-19... Read More
Wednesday June 17, 2020 0 comments
InDevR raises $7M in series A round with Adjuvant Capital investment
BOULDER -- InDevR, Inc. , a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced it has raised... Read More
Tuesday September 10, 2019 0 comments
InDevR launches next-gen software for Cypher One
BOULDER -- InDevR, Inc. , an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of the next-generation Cypher... Read More
Tuesday March 21, 2017 0 comments
InDevR licenses FDA influenza antibodies for VaxArray potency platform
BOULDER -- InDevR , a Boulder-based progressive analytical technology and life science instrumentation company, today announced it has entered into an agreement to license monoclonal antibodies... Read More
Tuesday January 17, 2017 0 comments
InDevR appoints Dawn Bitz chief commercial officer
BOULDER -- InDevR , a Boulder-based progressive analytical technology, life science instrumentation and medical device company, announced the appointment of Dawn Bitz as VP, Chief Commercial... Read More
Wednesday June 29, 2016 0 comments
CBSA: 2014 was successful year for major bioscience financings, acquistions and expansions
DENVER - The Colorado BioScience Association (CBSA) reports the state attained a number of key financings, acquisitions and expansions in its bioscience industry in 2014. "We've seen a... Read More
Tuesday December 23, 2014 0 comments
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
